| 摘要 |
<p>The present invention provides fused aryl and heteroaryl derivatives of Formula I that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.</p> |
| 申请人 |
INCYTE CORPORATION;LI, YUN-LONG;COMBS, ANDREW, P.;YUE, EDDY, W.;LI, HUI-YIN |
发明人 |
LI, YUN-LONG;COMBS, ANDREW, P.;YUE, EDDY, W.;LI, HUI-YIN |
